Evaluation of Short-Term Use of N-Acetylcysteine as a Strategy for Prevention of Anthracycline-Induced Cardiomyopathy: EPOCH Trial - A Prospective Randomized Study
Open Access
- 1 January 2013
- journal article
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 43 (3), 174-181
- https://doi.org/10.4070/kcj.2013.43.3.174
Abstract
Korean Circulation Journal 대한심장학회지 순환기 Jo SH, et al. Korean Circ J. 2013 Mar;43(3):174-181. https://doi.org/10.4070/kcj.2013.43.3.174Keywords
Funding Information
- Korean Society of Cardiology
This publication has 26 references indexed in Scilit:
- Tanshinone IIA prevents doxorubicin-induced cardiomyocyte apoptosis through Akt-dependent pathwayInternational Journal of Cardiology, 2012
- Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: Effects on left ventricular ejection fraction, troponin I and brain natriuretic peptideInternational Journal of Cardiology, 2011
- L-carnitine reduces doxorubicin-induced apoptosis through a prostacyclin-mediated pathway in neonatal rat cardiomyocytesInternational Journal of Cardiology, 2011
- Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme InhibitionCirculation, 2006
- Thrombopoietin Protects Against In Vitro and In Vivo Cardiotoxicity Induced by DoxorubicinCirculation, 2006
- Cardiovascular Complications of Cancer TherapyCirculation, 2004
- Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose ChemotherapyCirculation, 2004
- Subclinical Late Cardiomyopathy After Doxorubicin Therapy for Lymphoma in AdultsJournal of Clinical Oncology, 2004
- Cardiotoxicity of Chemotherapeutic AgentsDrug Safety, 2000
- Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine.JCI Insight, 1981